Paediatric asthma and smoking – initiative to identify and treat
Supporting information
The Health Innovation Manchester innovation for healthcare inequalities programme webpage contains:
-
our pilot launch news story
-
our insights report
-
a blog analysing inequalities for children and young people with asthma in Greater Manchester
-
our patient case study
-
educational resources.
Quotes
"Due to the effort professionals have made with raising concerns regarding the quality of the property, the family are due to change address within the next month. This will hopefully continue to have a positive impact on Kai's asthma. His school attendance has also improved since starting this treatment.
The objectives for this treatment have been met and hopefully will continue to improve over the coming months. These objectives were measured by the frequency, severity and duration of Kai's asthma exacerbations and the quantity of the oral steroids that were required. Since starting this treatment, the courses or oral steroids have reduced significantly. This subsequently, reduces the risk of systemic side effects such as adrenal suppression, weight gain, faltering growth, and immunosuppression, along with the psychosocial benefits of improved mood, improved sleep which results in improved concentration, therefore achieving improved outcomes at school.
Taking all these benefits into consideration, Kai has a better quality of life and can enjoy normal childhood activities which is essential for children to grow and develop physically, mentally and emotionally with their peers."
Victoria Abbott, Paediatric Asthma Nurse Specialist at The Royal Oldham Hospital, part of the Northern Care Alliance NHS Foundation Trust (NCA).
"I feel like it has improved Kai's asthma, he is staying out of hospital for longer periods of time and attending school more."
Kai's mother.
"Kai is one of the few patients who can be described as a severe asthmatic. We have an established pathway with colleagues at Royal Manchester Children's Hospital (RMCH) led by Professor Clare Murray who is an expert in this area.
Prior to biologics, he has been on the top of asthma treatment ladder and all aspects of care were addressed including compliance, technique, home environment and smoking along with education to both him and his parents.
His quality of life has improved hugely with this new treatment, and we have rarely seen him since then. Biologics have been a game changer for children in the severe asthma spectrum allowing them to enjoy what a child of their age should be able to do so."
Dr Prakash Kamath, Divisional Clinical Director at Bury Care Organisation, NCA.
Contact details
Cath Barrow
Senior Programme Development Lead at Health Innovation Manchester
Email: Cath.Barrow@healthinnovationmanchester.com,
info@healthinnovationmanchester.com, communications@healthinnovationmanchester.com
ISBN: 978-1-4731-7288-3
This page was last updated: